'For the quarter ending March 2024, consolidated net sales (including other operating income) of Lupin has increased 11.98% to Rs 4960.79 crore compared to quarter ended March 2023.  Operating profit margin has jumped from 13.04% to 20.09%, leading to 72.53% rise in operating profit to Rs 996.85 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 21.44% to 21.28%.   Purchase of finished goods cost fell from 15.48% to 12.86%.   Employee cost decreased from 18.19% to 17.51%.   Other expenses fell from 31.29% to 28.97%.   

Other income fell 21.52% to Rs 29.25 crore.  PBIDT rose 66.83% to Rs 1026.1 crore.  Provision for interest fell 22.97% to Rs 71.29 crore.  Loan funds declined from Rs 4,541.52 crore as of 31 March 2023 to Rs 2,921.77 crore as of 31 March 2024.  Inventories rose to Rs 4,953.90 crore as of 31 March 2024 from Rs 4,491.76 crore a...

• 

  (27-May-2025)

  Minda Corporation

  NP down 26.46%
• 

  (27-May-2025)

  General Insurance Corporation of India

  Net profit dip 17% in Q4FY2025
• 

  (27-May-2025)

  NTPC

  Sales up 5%, net up 23%
• 

  (27-May-2025)

  Aurobindo Pharma

  OP up 7.12% and NP remains flat